From discovery to the clinic: Seth Cheetham takes the helm at NBF
Associate Professor Seth Cheetham has been appointed Director of the National Biologics Facility (NBF), where he will help bridge the gap between university research discoveries and clinical development of breakthrough medicines.
Read full article →
From Tadpoles to Therapeutics: Laura’s journey to AIBN
Dr Laura Leighton, a postdoctoral fellow at AIBN’s BASE facility, applies her lifelong curiosity about biology to advancing mRNA therapeutics — making these medicines safer and more targeted.
Read full article →
AIBN researchers secure nearly $5 million in ARC Fellowship funding
Associate Professor Seth Cheetham received a $1.13M ARC Future Fellowship to develop ultra-stable “cloaked” mRNAs that could enhance manufacture efficiency and stability while reducing production costs.
Read full article →Australian trial of personalised vaccines to treat children with deadly brain cancers
A world-first clinical trial will test personalised mRNA vaccines for children with advanced brain tumours. The PaedNEO-VAX study, funded by a $2.578 million Australian Government investment, will use genome sequencing to design customised vaccines across 8 paediatric hospitals in Australia.
Read full article →
Getting personal in the fight against cancer
The University of Queensland has established a new laboratory dedicated to designing, manufacturing and delivering personalised mRNA cancer vaccines, addressing a critical gap in Australia's drug development infrastructure.
Read full article →
How personalised mRNA vaccines could revolutionise cancer treatment
Centre Director Dr Seth Cheetham presents at TEDxUQ on how custom-designed mRNA vaccine technology could transform the landscape of cancer therapies, enabling treatments tailored to each individual patient.
Watch on YouTube →